About 10 years ago, it was assumed that the process by which stem cells become specialized was irreversible. This has since been found to be inaccurate, and such a finding has allowed the team at BIOLIFE4D to return white blood cells into stem cells, then reprogram them into specialized cells to ultimately create a bioengineered human heart that is viable for transplantation. You may recognize the company from our previous episode that featured Dr. Jeffrey Morgan.

In this episode, we learn more about the incredible work at BIOLIFE4D, this time from Steven Morris, the CEO and president. Click play to hear more.

Podcast: Play in new window | Download | Embed